mail
versión imprimible
 
 

2nd CRISPR-Based Therapy Analytical Development Summit

Evvnt Promotion / evvnt
-
17.09.2024 - 19.09.2024  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
 
Temas de la conferencia
As CRISPR-based therapies become ever complex, drug developers urgently need to innovate the analytical tools available to effectively characterize their safety and efficacy profiles and agree upon gold standards moving forward. We are also witnessing increased regulatory scrutiny, with the FDA closely studying off-target analysis conducted ahead of the approval of Casgevy, prior to finalizing guidance on genome editing therapies in January.
Organizador profesional (PCO)
Hanson Wade
Observaciones
URL:
Brochure: https://go.evvnt.com/2433843-3?pid=4832

Speakers: Andrew Kernytsky, Principal Consultant, Next Gen Editing, Bryant Chia, Scientist, Analytical Chemistry and Structural Biology, Editas Medicine, and more
 

Información e inscripción:

https://go.evvnt.com/2433843-2?pid=4832
Ms. Jasmine Fletcher
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 2599.00 - USD 5796.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Österreichisches Rotes KreuznewTreeEuropean Public Health Association (EUPHA)Alumni Club Medizinische Universität WienÖsterreichische Akademie der ÄrzteHilfswerk AustriaCenter of ExcellenceHelix - Forschung & Beratung Wien